CMS says half of the reason for the largest Medicare Part B premium increase in 15 years is due to building up the Part B Medicare trust fund to take into account the potential cost of the controversial drug Aduhelm -- in case CMS approves its coverage -- while the other half is due to usual cost growth combined with the need to make up for Congress’ move to decrease premiums in 2021. The administration acknowledged the jump in premiums...